CXCL11 and neoplasm: Namkoong et al. demonstrated the adjuvant effect of CXCL11-Fc on tumor growth suppression with subsequent increased survival rates in a therapeutic tumor model, which was correlated with enhanced antigen-specific CD8+ T cell responses [35].